Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination therapy of emollients and topical corticosteroids is widely used in dermatology, particularly for the management of inflammatory skin conditions such as eczema, dermatitis, and psoriasis. Emollients are moisturizing agents that soothe, soften, and hydrate the skin by forming an occlusive barrier to prevent water loss. Topical corticosteroids are anti-inflammatory agents that reduce redness, swelling, itching, and irritation by suppressing local immune responses in the skin. The combination is not a single fixed pharmaceutical product but rather a regimen where both types of products are applied—often with emollients used to maintain hydration and barrier function while topical corticosteroids control inflammation during flare-ups. This approach helps maximize symptom relief while minimizing potential side effects from prolonged steroid use[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on emollient + topical corticosteroids.